Table 2 Recipient characteristics
SCD (n = 124) | ECD (n = 80) | DKT (n = 15) | p value | SCD vs DKT | ECD vs DKT | |
|---|---|---|---|---|---|---|
Age (year) | 49.3 ± 10.1 | 55.2 ± 10.1 | 63.7 ± 6.7 | < 0.01 | < 0.01 | < 0.01 |
Sex (M:F) | 80:44 | 57:23 | 13:2 | 0.19 | ||
Dilaysis duration (yrs) | 6.6 ± 4.5 | 6.1 ± 3.3 | 4.8 ± 2.5 | 0.17 | ||
History of KT (%) | 24 (19.4) | 6 (7.5) | 0 (0) | 0.02 | 0.15 | 0.99 |
BMI | 23.0 ± 3.5 | 23.6 ± 2.8 | 22.6 ± 2.9 | 0.06 | ||
DM (%) | 22 (17.7) | 28 (35.0) | 12 (80.0) | < 0.01 | < 0.01 | < 0.01 |
HTN (%) | 97 (78.2) | 70 (87.5) | 11 (73.3) | 0.16 | ||
HLA mm a | 3 (0–6) | 4 (0–6) | 4 (2–6) | < 0.01 | 0.03 | 0.59 |
PRA > 50% | 25 (20.8) | 6 (7.5) | 1 (6.7) | 0.03 | 0.55 | 0.99 |
DSA (+) | 21 (17.2) | 5 (6.25) | 0 (0) | 0.02 | 0.25 | 0.99 |
CIT (min) | 287.9 ± 83.6 | 281.7 ± 89.5 | 290.3 ± 107.0 | 0.90 | ||
Induction agent (rATG:basiliximab:rituximab) | 79:27:18 | 71:6:3 | 15:0:0 | < 0.01 | 0.03 | 0.99 |